3D Medicines Inc. (HKG:1244)
Hong Kong · Delayed Price · Currency is HKD 2.735
-0.115 (-4.04%)
Aug 27, 2026, 3:59 PM HKT
3D Medicines Market Cap
3D Medicines has a market cap or net worth of 700.87 million as of August 27, 2026. Its market cap has decreased by -63.97% in one year.
Market Cap
700.87M
Enterprise Value
325.88M
Revenue
396.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.74
ChartMarket Cap Chart
Since December 15, 2022, 3D Medicines's market cap has decreased from 7.02B to 700.87M, a decrease of -90.02%. That is a compound annual growth rate of -46.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 700.87M | -46.41% |
| Dec 31, 2025 | 1.31B | 73.29% |
| Dec 31, 2024 | 754.73M | -56.44% |
| Dec 29, 2023 | 1.73B | -81.75% |
| Dec 30, 2022 | 9.49B | 35.14% |
| Dec 15, 2022 | 7.02B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CANbridge Pharmaceuticals | 1.09B |
| Cloudbreak Pharma | 979.70M |
| Sunho Biologics | 970.43M |
| Kintor Pharmaceutical | 871.57M |
| JW (Cayman) Therapeutics Co. | 817.88M |
| Brii Biosciences | 743.46M |
| Cutia Therapeutics | 723.10M |
| Wuhan YZY Biopharma | 639.70M |